z-logo
Premium
Desmoplastic melanoma: an updated immunohistochemical analysis of 40 cases with a proposal for an additional panel of stains for diagnosis
Author(s) -
Plaza Jose A.,
Bonneau Peter,
Prieto Victor,
Sangueza Martin,
Mackin Alexander,
Suster David,
Bacchi Carlos,
Estrozi Bruna,
Kazakov Dmitry,
Kacerovska Denisa,
Falconieri Giovanni,
Suster Saul
Publication year - 2016
Publication title -
journal of cutaneous pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.597
H-Index - 75
eISSN - 1600-0560
pISSN - 0303-6987
DOI - 10.1111/cup.12654
Subject(s) - nestin , cd117 , pathology , immunohistochemistry , sox10 , melanoma , microphthalmia associated transcription factor , medicine , immunostaining , cd34 , biology , cancer research , stem cell , neural crest , microbiology and biotechnology , embryo , biochemistry , neural stem cell , tyrosinase , enzyme
Desmoplastic melanoma ( DM ) is histologically characterized by a proliferation of spindle melanocytes dispersed in a collagenous stroma that can be mistaken for a variety of neoplasms. The purpose of this study was to analyze 40 cases of DM with a comprehensive panel of immunohistochemical markers ( KBA .62, p16, Ezrin, WT ‐1, MITF ‐1, SOX ‐10, CD117 , SOX ‐2, nestin, PNL2 , p75, MART ‐1, gp100 and S100p) to obtain a more complete understanding of the potential use of these antibodies in the diagnosis of DM . We found that all cases of DM expressed p16, WT ‐1, SOX ‐10, nestin and S100p and 95% of cases expressed p75. There was variable expression with Ezrin, SOX ‐2, KBA .62, MART ‐1 and HMB ‐45. Most DMs did not express MITF ‐1, PNL2 and CD117 . Conditions that may enter in the histologic differential diagnosis of DM , including dermal scars, fibromatosis and dermatofibromas were also studied. Nearly all control cases also stained positive for p16 but were negative for WT1 , SOX10 , nestin, p75 and S‐100p, as well as for most of the other markers tested. We conclude that a panel of S‐100p, WT1 , SOX10 , p75 and nestin may constitute the optimal panel with the most sensitive and specific combination of immunostain available for the diagnosis of DM .

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom